A2B adenosine receptor antagonists: recent developments.

There are pharmacological evidences that A2B receptors are involved in inflammatory processes, such as asthma. For this reason, many efforts has been made for identifying selective A2B antagonists as antiasthmatic agents. The updated material related to this field has been rationalised and arranged in order to offer an overview of the topic.